These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2383063)

  • 21. B cell activation by pokeweed mitogen in cultures of normal peripheral blood lymphocytes depleted of T regulator subsets by treatment with OKT4 and OKT8 monoclonal antibodies.
    Jones BM
    Clin Exp Immunol; 1983 Mar; 51(3):461-9. PubMed ID: 6221842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum immunoglobulins in ankylosing spondylitis.
    Kendall MJ; Farr M; Williamson N
    Br Med J; 1973 Jul; 3(5872):172. PubMed ID: 4720774
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.
    Tani Y; Tiwana H; Hukuda S; Nishioka J; Fielder M; Wilson C; Bansal S; Ebringer A
    J Rheumatol; 1997 Jan; 24(1):109-14. PubMed ID: 9002020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyclonal activation of human lymphocytes in vitro. I. Characterization of the lymphocyte response to a T cell-independent B cell mitogen.
    Schuurman RK; Gelfand EW; Dosch HM
    J Immunol; 1980 Aug; 125(2):820-6. PubMed ID: 6967091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications for the role of cognate interactions in in vitro human B cell activation by Staphylococcus aureus Cowan I and pokeweed mitogen.
    Suzuki N; Sakane T; Ueda Y; Murakawa Y; Tsunematsu T
    J Clin Invest; 1986 Jan; 77(1):294-300. PubMed ID: 3484752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Polyclonal B-cell activation by so-called immunopotentiation (immunostimulants)].
    Kekow J; Hobusch G; Lüdemann J; Gross WL
    Dtsch Med Wochenschr; 1989 Jul; 114(28-29):1101-6. PubMed ID: 2787237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency analysis of human peripheral blood B cells producing IgM-rheumatoid factor. Differential effects of stimulation with monoclonal antibodies to CD3 and Staphylococcus aureus.
    Hirohata S; Inoue T; Miyamoto T
    J Immunol; 1990 Sep; 145(6):1681-6. PubMed ID: 2144005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation of whole blood cultures in patients with ankylosing spondylitis by a mitogen derived from Mycoplasma arthritidis (MAS) and other mitogens.
    Brand JM; Neustock P; Kruse A; Alvarez-Ossorio L; Schnabel A; Kirchner H
    Rheumatol Int; 1997; 16(5):207-11. PubMed ID: 9032820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyclonal B lymphocyte activation in progressive systemic sclerosis.
    Famularo G; Giacomelli R; Alesse E; Cifone MG; Morrone S; Boirivant M; Danese C; Perego MA; Santoni A; Tonietti G
    J Clin Lab Immunol; 1989 Jun; 29(2):59-63. PubMed ID: 2632802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphological studies on plasma cell differentiation induced by Staphylococcus aureus Cowan I strain in human peripheral blood B-lymphocytes.
    Yamamura M; Nakamura S; Matsuda T; Hattori K
    Nihon Ketsueki Gakkai Zasshi; 1986 Feb; 49(1):101-14. PubMed ID: 3486541
    [No Abstract]   [Full Text] [Related]  

  • 31. Abnormal B cell response to T cell-independent polyclonal B cell activators in haemophilia A.
    Kekow J; Plendl H; Gross WL
    Clin Exp Immunol; 1986 May; 64(2):376-81. PubMed ID: 3017621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cellular immunity during ankylosing spondylitis].
    Sany J; Clot J; Andary M
    Rev Rhum Mal Osteoartic; 1980 Jun; 47(6):403-8. PubMed ID: 7455598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral B-lymphocyte markers and function in IgA nephropathy.
    Magyarlaki T; Davin JC; Szabados E; Kocsis B; Nagy J
    Clin Nephrol; 1990 Mar; 33(3):123-9. PubMed ID: 2108834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe combined immunodeficiency with B lymphocytes: in vitro correction of defective immunoglobulin production by addition of normal T lymphocytes.
    Seeger RC; Robins RA; Stevens RH; Klein RB; Waldman DJ; Zeltzer PM; Kessler SW
    Clin Exp Immunol; 1976 Oct; 26(1):1-10. PubMed ID: 1087209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiglobulins in ankylosing spondylitis.
    Arana RM; de la Vega MT; Porrini A; Garcia Morteo O
    J Rheumatol; 1975 Sep; 2(3):303-7. PubMed ID: 52709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune function in ankylosing spondylitics and their relatives: influence of disease and HLA B27.
    Christiansen FT; Hawkins BR; Dawkins RL
    Clin Exp Immunol; 1978 Aug; 33(2):270-5. PubMed ID: 102477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunocompetence in lung cancer. Relationship to extent of tumor burden and histologic type.
    Pillai MR; Balaram P; Padmanabhan TK; Abraham T; Hareendran NK; Nair MK
    Cancer; 1989 Nov; 64(9):1853-8. PubMed ID: 2551475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-cell immunoregulation in patients with inflammatory bowel disease. II. Enhanced suppressor T-cell activity in ulcerative colitis.
    Kramer JK; Depew WT; Szewczuk MR
    J Clin Lab Immunol; 1988 Jan; 25(1):19-27. PubMed ID: 2968458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The immunoglobulins in ankylosing spondylitis].
    Kriegel W; Burger R; Kapp W; Alexopulos J
    Verh Dtsch Ges Rheumatol; 1969; 1():206-11. PubMed ID: 5314829
    [No Abstract]   [Full Text] [Related]  

  • 40. Autoantibodies to collagens in Japanese patients with ankylosing spondylitis.
    Tani Y; Sato H; Hukuda S
    Clin Exp Rheumatol; 1997; 15(3):295-7. PubMed ID: 9177925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.